top of page
Search

You Can’t Recover if You Aren’t Here: How Harm Reduction Bridges the Treatment Gap

When we talk about supporting someone who is struggling with substance use, our instinct is often to push for the fastest, most complete solution: stop now, get clean, turn it all around. This usually comes from a place of good intentions. But good intentions, without the right framework, can often make things more dangerous. Taking a "Safety First" mindset at the heart of harm reduction asks us to pause, recalibrate, and ask a harder question: What does success look like today?

Life Is the Priority

One of the most foundational principle of harm reduction is also its most sobering: you cannot support someone who is no longer here.

Overdose, infection, untreated illness — the risks associated with active substance use are not hypothetical. They are immediate and, in some cases, fatal. When we demand total transformation as the price of our support, we may be withdrawing the very lifeline that keeps a person connected to care, community, and the possibility of change. As the Agency for Healthcare Research and Quality says, harm reduction "prioritizes the health and well-being of individuals, even if they continue to use substances" (Salisbury-Afshar, 2023). The logic is straightforward: a person who is alive can be supported, engaged, and can recover. A person who has died from a preventable overdose cannot.

This is why harm reduction programs invest heavily in tools like naloxone distribution and syringe service programs — not as endorsements of drug use, but as commitments to keeping people alive long enough for something to change.

According to the Centers for Disease Control and Prevention (CDC), in 2022 alone, 54.6 million people needed substance use treatment, but only 13.1 million received it (CDC, 2024).

The gap between need and access is enormous. Harm reduction strategies fill that gap by meeting people in the reality of where they are, not the ideal of where we wish they were.

Shifting the Definition of Success

Traditional addiction treatment has long been organized around a single metric: total abstinence. If a person relapses, they have failed. If they are not ready to stop, they are not ready for help. This framework, while well-intentioned, has a significant structural flaw — it excludes the people who need support the most.

Harm reduction redefines what winning looks like. Rather than measuring success by whether someone stops using substances entirely, it measures success by whether someone is safer today than they were yesterday. Did they use a clean needle instead of a shared one? Did they carry naloxone? Did they check in with a service provider? Did they use in a location where someone could help them if something went wrong? Each of these is a meaningful, life-saving success — even if it does not look like the finish line we imagined.

This shift in framing is not a lowering of standards. It is a recognition of how change actually works.

Salisbury-Afshar (2023) makes this point directly: "Abstinence absolutely is part of harm reduction, but it is not the only acceptable goal or outcome. It is about really being inclusive, patient-centered, and listening to where people are and supporting them in their own goals."

Harm reduction does not abandon the possibility of abstinence — it creates the conditions under which abstinence becomes more achievable by building trust, reducing health risks, and keeping people engaged in care over time.

One striking example of this comes from research on syringe service programs: people who participated in one were five times more likely to enter formal treatment than those who did not use such programs (Charlie Health, 2024). The very programs critics describe as "enabling" drug use are, in practice, functioning as on-ramps to recovery. By lowering the threshold of engagement, harm reduction paradoxically increases the likelihood of the longer-term outcomes that everyone hopes for.

Reducing Shame: Why Ultimatums Backfire

Perhaps the most consequential — and least-discussed — dimension of the abstinence-only approach is what it does to shame.

People who struggle with substance use disorders already carry enormous psychological weight. The National Institute on Drug Abuse (NIDA) notes that people with substance use disorders "may already feel guilt and may blame themselves for their illness," and that these feelings of shame and isolation "may in turn reinforce drug-seeking behavior" (NIDA, 2024). In other words, shame does not motivate change — it fuels the very behavior it is meant to interrupt.

High-pressure ultimatums — "get clean or lose everything" — may feel like tough love, but research consistently shows they drive use further underground. When people fear judgment, loss of housing, loss of custody, or rejection from family, they do not stop using. They stop disclosing. They use alone, in hidden places, without the safety net of anyone who could intervene in a crisis. Research has found that shame is associated with treatment-seeking delays, recurrence of substance use symptoms, and treatment dropout — exactly the opposite of the outcomes ultimatums are meant to produce (Earnshaw et al., 2021).

The mechanism is well-documented: all-or-nothing approaches "that moralize and shame people who engage in the activity don't work. In fact, these approaches can push people to hide their behavior and make them less likely to adhere to risk mitigation advice, making it even more dangerous" (Everyday Activism Network, 2023). When use goes underground, so does access to information about safer practices, naloxone availability, and pathways to care.

The numbers tell the same story at a population level. According to data cited in recent peer-reviewed research, 48.5 million individuals aged 12 or older in the United States had a substance use disorder in 2023 — yet only 24% received treatment (as reported in PMC, 2024, citing SAMHSA, 2024). Stigma is among the most frequently cited barriers to seeking that treatment. People know help exists. Shame is what stops them from asking for it.

The Safety First mindset addresses shame not by lowering expectations, but by removing moral judgment as the price of admission to support. It says: You are a person with inherent worth. Your safety matters right now, regardless of whether you are ready to stop. That message — consistent, non-punitive, and genuinely caring — creates the trust that makes honest engagement possible. And honest engagement is where real change begins.


Photo credit: The Overdose Prevention Engagement Network (OPEN)
Photo credit: The Overdose Prevention Engagement Network (OPEN)

Understanding the Safety First mindset requires a willingness to sit with discomfort. It can feel counterintuitive to offer support without conditions, to redefine success as "safer today" rather than "abstinent tomorrow," and to see shame reduction as a clinical strategy rather than a moral compromise. But the evidence is consistent: approaches that keep people alive, reduce stigma, and lower the barriers to engagement save more lives and open more doors to recovery than those that demand perfection as the price of care.

The first goal is always to ensure that there is a tomorrow. Everything else can be worked on from there.


References

Centers for Disease Control and Prevention. (2024). Stigma reduction. Stop Overdose. https://www.cdc.gov/stop-overdose/stigma-reduction/index.html

Charlie Health. (2024). Harm reduction vs. abstinence. https://www.charliehealth.com/post/what-is-harm-reduction

Earnshaw, V. A., Smith, L. R., Cunningham, C. O., & Copenhaver, M. M. (2021). Stigma and substance use disorders: A clinical, research, and advocacy agenda. Psychiatric Services, 72(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC8168446/

Everyday Activism Network. (2023). Defining harm reduction and abstinence: The pros and cons of two public health approaches. https://www.everydayactivismnetwork.org/archive/harm-reduction-abstinence

National Institute on Drug Abuse. (2024). Stigma and discrimination. https://nida.nih.gov/research-topics/stigma-discrimination

PMC. (2024). Substance use, stigma, and coping in treatment: A qualitative study of participant perspectives. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC12494836/

Salisbury-Afshar, E. (2023). Harm reduction strategies to improve safety for people who use substances. PSNet — Agency for Healthcare Research and Quality. https://psnet.ahrq.gov/perspective/harm-reduction-strategies-improve-safety-people-who-use-substances

Substance Abuse and Mental Health Services Administration. (2024). Stigma and language: The power of perceptions and understanding. https://www.samhsa.gov/substance-use/treatment/stigma-language


 
 
 

Recent Posts

See All
bottom of page